KTWO · Insider Trading
K2 Capital Acquisition Corporation Class A Ordinary Share
Every open-market purchase and sale reported by KTWO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2018-09-04 | Gregory S Cole | Chief Financial Officer | MIXED | — | −$1.49M |
| 2018-08-17 | John Philip Md Kostuik | Chief Medical Officer | F | −656 | −$13.19K |
| 2018-08-17 | George Z Moratis | Global Accounting Officer | Sell | −695 | −$14.03K |
| 2018-08-17 | Gregory S Cole | Chief Financial Officer | Sell | −1,480 | −$29.72K |
| 2018-07-27 | George Z Moratis | Global Accounting Officer | A | +2,383 | — |
| 2018-07-06 | Gregory S Cole | Chief Financial Officer | Sell | −867 | −$19.48K |
| 2018-07-03 | John Philip Md Kostuik | Chief Medical Officer | F | −478 | −$10.76K |
| 2018-07-03 | Eric D Major | President & CEO | F | −2,107 | −$47.41K |
| 2018-07-03 | Lane E Major | Chief Operating Officer | F | −817 | −$18.38K |
| 2018-06-08 | Gregory S Cole | Chief Financial Officer | F | −1,386 | −$32.70K |
| 2018-06-08 | John Philip Md Kostuik | Chief Medical Officer | F | −427 | −$10.07K |
| 2018-06-08 | Lane E Major | Chief Operating Officer | F | −912 | −$21.51K |
| 2018-06-08 | George Z Moratis | Global Accounting Officer | Sell | −455 | −$10.38K |
| 2018-06-08 | Eric D Major | President & CEO | F | −4,399 | −$103.77K |
| 2018-06-07 | John Philip Md Kostuik | Chief Medical Officer | A | +4,639 | — |
| 2018-06-07 | Gregory S Cole | Chief Financial Officer | A | +13,777 | — |
| 2018-06-07 | Daniel A Pelak | Director | A | +2,437 | — |
| 2018-06-07 | George Z Moratis | Global Accounting Officer | A | +4,408 | — |
| 2018-06-07 | Sean Traynor | Director | A | +2,437 | — |
| 2018-06-07 | Brett Brodnax | Director | A | +2,437 | — |
| 2018-06-07 | Lane E Major | Chief Operating Officer | A | +12,717 | — |
| 2018-06-07 | Eric D Major | President & CEO | A | +44,086 | — |
| 2018-06-07 | Paul B. Queally | Director | A | +2,437 | — |
| 2018-06-07 | Ray A Ranelli | Director | A | +2,437 | — |
| 2018-06-07 | Carlos A Ferrer | Director | A | +2,437 | — |
| 2018-04-20 | Ray A Ranelli | Director | A | +5,159 | — |
| 2017-08-24 | John Philip Md Kostuik | Chief Medical Officer | Sell | −1,332 | −$31.04K |
| 2017-08-16 | George Z Moratis | Global Accounting Officer | Sell | −770 | −$18.55K |
| 2017-08-16 | John Philip Md Kostuik | Chief Medical Officer | Sell | −1,090 | −$26.25K |
| 2017-08-16 | Gregory S Cole | Chief Financial Officer | Sell | −2,350 | −$56.59K |
| 2017-08-16 | Eric D Major | President & CEO | F | −4,248 | −$101.87K |
| 2017-08-15 | Gregory S Cole | Chief Financial Officer | MIXED | — | −$555.19K |
| 2017-07-05 | John Philip Md Kostuik | Chief Medical Officer | F | −783 | −$19.07K |
| 2017-07-05 | Eric D Major | President & CEO | F | −2,317 | −$56.44K |
| 2017-07-05 | Gregory S Cole | Chief Financial Officer | Sell | −956 | −$23.26K |
| 2017-06-16 | Gregory S Cole | Chief Financial Officer | MIXED | — | −$581.41K |
| 2017-06-12 | Carlos A Ferrer | Director | A | +2,521 | — |
| 2017-06-08 | Ray A Ranelli | Director | A | +2,521 | — |
| 2017-06-08 | Sean Traynor | Director | A | +2,521 | — |
| 2017-06-08 | Paul B. Queally | Director | J | −5,383,672 | — |
| 2017-06-08 | Gregory S Cole | Chief Financial Officer | A | +13,810 | — |
| 2017-06-08 | Carlos A Ferrer | Director | A | +2,521 | — |
| 2017-06-08 | John Philip Md Kostuik | Chief Medical Officer | A | +4,727 | — |
| 2017-06-08 | George Z Moratis | Global Accounting Officer | A | +4,491 | — |
| 2017-06-08 | Paul B. Queally | Director | A | +2,521 | — |
| 2017-06-08 | Daniel A Pelak | Director | A | +2,521 | — |
| 2017-06-08 | Brett Brodnax | Director | A | +2,521 | — |
| 2017-06-08 | Eric D Major | President & CEO | A | +43,840 | — |
| 2017-05-30 | John Philip Md Kostuik | Chief Medical Officer | Sell | −50,000 | −$1.14M |
| 2017-05-15 | George Z Moratis | Global Accounting Officer | Sell | −1,000 | −$21.77K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KTWO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.